Key Takeaways
- • Canada's early-stage VC market contracted sharply in Q1 2026, with 40% fewer founders raising capital compared to Q1 2025 and total capital raised down 40% year-over-year, according to RBCx data tracking over 700 pre-seed and seed-stage companies.
- • Market concentration has intensified dramatically: five well-established funds captured 80% of total capital raised in 2025, while all other funds experienced approximately 90% decline in fundraising since 2021.
- • Emerging managers raised $2.8 billion in 2026—36% below anticipated levels—signaling structural constraints in the allocation pipeline for early-stage capital.
- • Average seed round size has remained stable at approximately $3 million despite the funding contraction, indicating that startup capital requirements have not decreased while fewer founders can access capital, creating a widening accessibility gap.
- • Deeptech sectors including cleantech and life sciences remain heavily dependent on venture funding and face particular pressure, as AI-driven cost reductions do not fully offset the funding challenges facing capital-intensive early-stage companies.
Summary
The data underscores a critical structural imbalance in Canada's VC market: capital concentration at the top tier has reached unprecedented levels. Five established funds accounted for 80% of all capital raised in 2025, leaving considerably less capital available for emerging managers and early-stage companies than historical patterns would suggest. Excluding those five dominant funds, fundraising among all other market participants declined approximately 90% since 2021, indicating a severe compression in capital availability outside the largest established players. Emerging managers specifically raised $2.8 billion—36% below anticipated levels—further constraining the pipeline for seed and pre-seed stage funding.
A particularly acute signal emerges from the disconnect between capital availability and funding demand. While the average seed round size has remained stable at approximately $3 million throughout 2025 and into Q1 2026, fewer founders are entering the fundraising market. This stability in round size despite declining access suggests that startup capital requirements have not shifted downward; rather, a growing population of early-stage companies is unable to secure funding at all. Deeptech sectors, particularly cleantech and life sciences, remain heavily reliant on venture capital and face compounded pressure from this market tightening. Although AI-driven tools are reducing operational costs for some startups, capital-intensive deeptech companies cannot offset the fundamental funding constraint through efficiency gains alone.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.